Biotech experience of the rapid and nimble acceleration of clinical programmes in the light of Covid-19

Biotech experience of the rapid and nimble acceleration of clinical programmes in the light of Covid-19

  • When a vaccine leaves the laboratory, its fate is determined by society rather than science
  • All disease outbreaks are accompanied by outbreaks of fear, moralization and action
  • How can you design vaccines to avoid provoking or amplifying fears?
  • Avoid ‘deficit thinking’ about the intended recipients of the vaccine
  • Mitigating COVID-19 risks with virtualization methods